Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)

BACKGROUND: The quadrivalent human papillomavirus vaccine has been provided in Australia through the National Human Papillomavirus Vaccination Program since April 2007. National registry data demonstrates good coverage of the vaccine, with 73% of school-aged girls having received all three doses. To...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Young, Elisa J, Tabrizi, Sepehr N, Brotherton, Julia ML, Wark, John D, Pyman, Jan, Saville, Marion, Wrede, C David, Jayasinghe, Yasmin, Tan, Jeffrey, Gertig, Dorota M, Pitts, Marian, Garland, Suzanne M
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3751671/
https://ncbi.nlm.nih.gov/pubmed/23777549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-296
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares